Germany's Merck KGaA has been working hard to expand its healthcare product pipeline in recent months, and has now appointed industry veteran David Weinreich to oversee that process. Weinreich has ...
With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for increasing the number of treatments available. However, as Ben Hargreaves discovers, research into ...
Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback